Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe
Fulvestrant injection is an estrogen receptor antagonist indicated for the treatment of breast cancer
Live Webinar: Know key strategies in selecting preparative LC columns |
Recover your password.
A password will be e-mailed to you.